Biological Background of GNG11

GNG11 encodes the gamma-11 subunit of heterotrimeric guanine nucleotide-binding proteins (G proteins), which are central mediators of intracellular signaling downstream of G protein-coupled receptors (GPCRs). Heterotrimeric G proteins are composed of three subunits: alpha (Gα), beta (Gβ), and gamma (Gγ). The Gβγ dimer, formed by the beta and gamma subunits, acts as a functional unit that modulates effector proteins including adenylyl cyclase, phospholipase C, and various ion channels.

The gamma subunits, including GNG11, are critical for membrane anchoring of the Gβγ complex via lipid modification (typically prenylation at a C-terminal CaaX motif) and for conferring specificity to Gβγ-effector interactions. GNG11 is expressed in a variety of human tissues and has been implicated in cardiovascular regulation, angiogenesis, and broader GPCR signaling networks. Dysregulation of GNG11 expression has been observed in certain disease contexts, making it a relevant target for mechanistic and translational research.

Recombinant Protein Preparation and Quality Considerations

Recombinant Human GNG11 Protein (rp368014) is produced using recombinant expression systems to deliver a research-grade protein suitable for in vitro biochemical and cell-based assays. When working with recombinant G protein subunits such as GNG11, researchers should consider the following quality and handling parameters:

• Expression System: Recombinant gamma subunits are commonly expressed in bacterial (e.g., E. coli), insect (baculovirus), or mammalian systems. The choice of system affects post-translational modifications such as prenylation, which is important for native membrane association. Researchers should consult the product datasheet for expression system details.
• Purity: Research-grade recombinant proteins should meet defined purity thresholds, typically assessed by SDS-PAGE and/or HPLC. Confirm purity specifications from the product Certificate of Analysis (CoA).
• Formulation and Storage: Lyophilized or solution formulations require specific reconstitution and storage conditions to maintain protein activity. Store according to the product datasheet instructions; avoid repeated freeze-thaw cycles.
• Functional Validation: Confirm biological activity via appropriate functional assays relevant to your experimental system before use in critical experiments.

Research Applications of Recombinant Human GNG11 Protein

Recombinant Human GNG11 Protein supports a range of experimental applications in cell biology, biochemistry, and pharmacology. Key applications include:

• Protein–Protein Interaction Studies: GNG11 can be used in pull-down assays, co-immunoprecipitation setups, and surface plasmon resonance (SPR) experiments to map interactions between Gβγ complexes and downstream effectors or regulatory proteins.
• Biochemical Reconstitution: Recombinant GNG11 is suitable for in vitro reconstitution of heterotrimeric G protein complexes to study assembly, activation kinetics, and effector modulation under defined conditions.
• GPCR Signaling Research: As a component of the Gβγ signaling axis, GNG11 protein supports mechanistic investigations of GPCR pathway activation, including studies on adenylyl cyclase regulation and phospholipase C activation.
• Drug Discovery and Target Validation: GNG11 is relevant as a tool protein for screening compounds that modulate Gβγ signaling, an emerging pharmacological target area.
• Structural Biology: Recombinant GNG11 may be used as a component in structural studies (e.g., cryo-EM, X-ray crystallography) of G protein complexes.

Experimental Protocol Guidance

The following general guidelines support successful use of Recombinant Human GNG11 Protein in laboratory experiments:

1. Reconstitution: If supplied in lyophilized form, reconstitute the protein in the buffer recommended on the product datasheet. Centrifuge briefly after reconstitution to remove any insoluble material. Prepare aliquots to avoid repeated freeze-thaw cycles.
2. Working Concentration: Optimal working concentrations vary by assay type. Perform a titration experiment to determine the appropriate concentration for your specific application. Refer to published literature on Gβγ subunit assays for guidance on starting concentrations.
3. Compatibility: Verify buffer compatibility with your assay reagents. Reducing agents (e.g., DTT) and detergents present in protein formulations may interfere with certain assay formats such as ELISA or AlphaScreen.
4. Controls: Include appropriate positive and negative controls in all experiments. Use a validated Gβγ complex or known interacting partner as a positive control where feasible.
5. Handling: Handle recombinant proteins on ice. Minimize exposure to protease contamination by using clean, sterile labware and adding protease inhibitors where appropriate.